Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 7/20 | 0.38 |
| ▸ | ITGAV | P06756 | 7/20 | 0.38 |
| ▸ | ITGB1 | P05556 | 1/20 | 0.38 |
| ▸ | ITGA5 | P08648 | 1/20 | 0.38 |
| ▸ | ADRA2A | P08913 | 4/20 | 0.36 |
| ▸ | ADRA2C | P18825 | 4/20 | 0.36 |
| ▸ | ADRA1D | P25100 | 4/20 | 0.36 |
| ▸ | ADRA1A | P35348 | 4/20 | 0.36 |
| ▸ | ADRA1B | P35368 | 4/20 | 0.36 |
| ▸ | ADRA2B | P18089 | 3/20 | 0.36 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.34 |
| ▸ | CXCR4 | P61073 | 5/20 | 0.33 |
| ▸ | GRM5 | P41594 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.32 |
| ▸ | FEN1 | P39748 | 1/20 | 0.32 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26538782 | 0.80 | ITGB3 (0.39) | ITGB3ITGAVITGB1ITGA5ADRA2A | |
| SCHEMBL8172614 | 0.78 | ITGAV (0.38) | ITGB3ITGAVITGB1ITGA5PDE10A | |
| SCHEMBL2494472 | 0.77 | ITGAV (0.41) | ITGB3ITGAVITGB1ITGA5PDE10A | |
| SCHEMBL24440037 | 0.77 | ITGAV (0.39) | ITGB3ITGAVITGB1ITGA5ADRA2A | |
| SCHEMBL26457526 | 0.77 | ALDH1A1 (0.40) | ITGB3ITGAVITGB1ITGA5ADRA2A | |
| SCHEMBL12807108 | 0.77 | KCNH2 (0.42) | ITGB3ITGAVITGB1ITGA5PDE10A | |
| SCHEMBL22864131 | 0.77 | CXCR4 (0.44) | ITGB3ITGAVCXCR4ITGA2B | |
| SCHEMBL8039387 | 0.75 | ITGAV (0.40) | ITGB3ITGAVITGB1ITGA5PDE10A | |
| SCHEMBL14476045 | 0.74 | GRM5 (0.39) | ITGB3ITGAVITGB1ITGA5ADRA2A | |
| SCHEMBL24630901 | 0.73 | HIF1A (0.47) | ALOX5APFEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220315534-A1 | BETA ADRENERGIC AGONIST AND METHODS OF USING THE SAME | CURASEN THERAPEUTICS, INC. | 2022-10-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220315534-A1 | BETA ADRENERGIC AGONIST AND METHODS OF USING THE SAME | ADRB2, ADRB1, ADRA2C | ITGB3 942/4885ITGAV 904/4885ITGB1 1261/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.